Leiter Reports: A Philosophy Blog

News and views about philosophy, the academic profession, academic freedom, intellectual culture, and other topics. The world’s most popular philosophy blog, since 2003.

  1. Mark's avatar

    In theory, the US retains a launch-on-warning *capacity* for the ICBMs. But I’m pretty sure they’re not on an actual…

  2. David Wallace's avatar

    On (4), and with the usual caveat that I’m not an expert here: The US has 400 land-based ICBMs, carrying…

  3. David Wallace's avatar

    In itself, not much. (A few quibbles: the estimates of deployed warheads are implausibly precise; the assessment of nuclear winter…

  4. LFC's avatar
  5. Rob's avatar
  6. Dan Schwarcz's avatar
  7. Milan Markovic's avatar

Oxford/AstraZeneca vaccine: 70% effective on average

Another two-dose vaccine, that was 90% effective in the group that got a half-dose first, and then a full dose second (but less effective in the group that got a full dose each time).  Note that in this trial they also checked for asymptomatic infections.   Various experts comment here.

Leave a Reply to Jonathan Birch Cancel reply

Your email address will not be published. Required fields are marked *

One response to “Oxford/AstraZeneca vaccine: 70% effective on average”

  1. I fully agree with Sheila Bird's take in the reactions linked above. We have to wait for proper, published data. These press releases… they aren't enough to base a firm opinion on.

    —–
    KEYWORDS:
    Primary Blog

Designed with WordPress